LabCorp Receives Authorization for COVID-19 Sample Pooling | Business & Finance
BURLINGTON, N.C.–(BUSINESS WIRE)–Jul 25, 2020–
LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced it received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) permitting diagnostic testing of groups of individuals for active COVID-19 infections